# AEMD (Aethlon Medical, Inc.) - SEC EDGAR Financial Statements

> Aethlon Medical, Inc. reported $7.33M in total assets and a net loss of $8.07M through March 31, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/AEMD
- Markdown: https://convexityos.com/fundamentals/AEMD.md
- SEC CIK: 0000882291
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000882291&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Mar 31, 2026 |
| Operating Income | FY 2026 | -$8.25M | Operating profit |
| Net Income | FY 2026 | -$8.07M | GAAP bottom line |
| Diluted EPS | FY 2026 | -$8.01 | Split-adjusted |
| Free Cash Flow | FY 2026 | -$7.00M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $6.49M | Total debt: $172K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $0 | $574K | $294K | $659K | $650K | $230K | $150K | $392K |
| Research & Development | $1.91M | $2.21M | $2.52M | $2.75M | $2.34M | $2.07M | $927K | $896K | $586K | $673K |
| Total Operating Expenses | $7.29M | $9.34M | $12.64M | $12.47M | $10.72M | $8.55M | $6.58M | $6.23M | $4.98M | $6.49M |
| **Operating Income** | -$7.29M | -$9.34M | -$12.64M | -$11.90M | -$10.42M | -$7.89M | -$5.93M | -$6.00M | -$4.83M | -$6.10M |
| **EBITDA** | -$6.97M | -$9.00M | -$12.28M | -$11.66M | -$10.30M | -$7.85M | -$5.90M | -$5.97M | -$4.80M | -$6.07M |
| Interest Income | $157K | $298K | $428K | $11K | $0 | -- | -- | -- | -- | -- |
| Interest Expense | $14K | $10K | -- | -- | -- | $1.6K | $54K | $220K | $362K | $304K |
| Income Before Tax | -$7.15M | -$13.39M | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$7.15M | -$13.39M | -$12.21M | -$12.03M | -$10.42M | -$7.89M | -$6.37M | -$6.19M | -$5.68M | -$7.28M |
| Basic EPS | -$2,652.50 | -$21,442.50 | -$7,774,000.00 | -$9,376,000.00 | -$11,360,000.00 | -$10,400,000.00 | -$29,920,000.00 | -$82,080,000.00 | -$1,600,000.00 | -$15,040,000.00 |
| **Diluted EPS** | -$2,652.50 | -$21,442.50 | -$7,774,000.00 | -$9,376,000.00 | -$11,360,000.00 | -$10,400,000.00 | -$29,920,000.00 | -$82,080,000.00 | -$1,600,000.00 | -$15,040,000.00 |
| Basic Shares Outstanding | 2.7K | 624 | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
| Diluted Shares Outstanding | 2.7K | 624 | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $481K | $549K | $590K | $533K | $294K | $524K | $1.33M | $240K |
| Total Operating Expenses | $2.68M | $1.58M | $1.93M | $2.06M | $1.51M | $1.79M | $2.00M | $1.81M |
| **Operating Income** | -$2.68M | -$1.58M | -$1.93M | -$2.06M | -$1.51M | -$1.79M | -$2.00M | -$1.81M |
| **EBITDA** | -$2.59M | -$1.51M | -$1.85M | -$1.98M | -$1.43M | -$1.71M | -$1.92M | -$1.73M |
| Interest Income | -- | -- | -- | -- | -- | $36K | -- | -- |
| **Net Income** | -$2.62M | -$1.55M | -$1.88M | -$2.02M | -$1.49M | -$1.76M | -$6.25M | -$1.75M |
| Basic EPS | -$2.60 | -$20.10 | -- | -$6,125.00 | -$18.70 | -$212.10 | -- | -$25,125.00 |
| **Diluted EPS** | -$2.60 | -$20.10 | -- | -$6,125.00 | -$18.70 | -$212.10 | -- | -$25,125.00 |
| Basic Shares Outstanding | 1.0M | 76.9K | -- | 329 | 79.5K | 8.3K | -- | 70 |
| Diluted Shares Outstanding | 1.0M | 76.9K | -- | 329 | 79.5K | 8.3K | -- | 70 |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.03M | $5.50M | $5.44M | $14.53M | $17.07M | $9.86M | $9.60M | $3.83M | $6.97M | $1.56M |
| **Cash & Short-Term Investments** | $5.03M | $5.50M | $5.44M | $250K | $17.07M | $9.86M | $9.60M | $3.83M | $6.97M | $1.56M |
| Accounts Receivable, Net | -- | -- | -- | $0 | $128K | $149K | $207K | $0 | $75K | $0 |
| **Total Current Assets** | $5.57M | $5.95M | $6.23M | $15.09M | $18.16M | $10.35M | $10.04M | $4.04M | $7.23M | $1.60M |
| Property, Plant & Equipment, Net | $357K | $676K | $1.02M | $1.14M | $441K | $161K | $140K | $6.0K | $28K | $29K |
| Intangible Assets | $0 | $550 | $1.1K | $1.6K | $2.2K | $57K | $58K | $67K | $76K | $85K |
| **Total Non-Current Assets** | $764K | $1.41M | $2.02M | $2.42M | $1.26M | $317K | $347K | $85K | $122K | $129K |
| **Total Assets** | $6.33M | $7.36M | $8.25M | $17.51M | $19.42M | $10.67M | $10.39M | $4.12M | $7.35M | $1.73M |
| Accounts Payable | $385K | $535K | $778K | $433K | $500K | $338K | $285K | $132K | $124K | $484K |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $345K | $115K | $100K | $0 | -- | -- |
| Other Current Liabilities | $657K | $472K | $215K | $589K | $697K | $697K | $472K | $646K | $263K | $69K |
| **Total Current Liabilities** | $1.45M | $1.90M | $1.83M | $1.51M | $1.82M | $1.38M | $1.07M | $1.82M | $478K | $612K |
| **Total Non-Current Liabilities** | $0 | $337K | $650K | $940K | $603K | $0 | $43K | $0 | $841K | $519K |
| **Total Liabilities** | $1.45M | $2.24M | $2.48M | $2.44M | $2.43M | $1.38M | $1.11M | $1.82M | $1.32M | $1.13M |
| **Total Debt (incl. Leases)** | $337K | $650K | $940K | $1.21M | $729K | $43K | $141K | -- | -- | -- |
| Common Stock | $314 | $259 | $329 | $2.3K | $15K | $12K | $9.4K | $1.3K | $18K | $8.8K |
| Retained Earnings | -$175.1M | -$168.0M | -$154.6M | -$142.4M | -$130.3M | -$119.9M | -$112.0M | -$105.7M | -$99.46M | -$93.78M |
| Accumulated Other Comp. Income | -$33K | -$17K | -$6.9K | -$6.1K | $0 | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $4.89M | $5.12M | $5.77M | $15.06M | $16.99M | $9.43M | $9.41M | $2.43M | $6.13M | $676K |
| Total Equity | $4.89M | $5.12M | $5.77M | $15.06M | $16.99M | $9.29M | $9.28M | $2.30M | $6.03M | $595K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.49M | $4.93M | $5.03M | $6.96M | $5.85M | $3.77M | $5.50M | $4.83M |
| **Cash & Short-Term Investments** | $6.49M | $4.93M | $5.03M | $6.96M | $5.85M | $3.77M | $5.50M | $4.83M |
| **Total Current Assets** | $6.86M | $5.61M | $5.57M | $7.14M | $6.25M | $4.05M | $5.95M | $4.97M |
| Property, Plant & Equipment, Net | $215K | $293K | $357K | $434K | $514K | $594K | $676K | $762K |
| Intangible Assets | -- | -- | $0 | $138 | $275 | $413 | $550 | $688 |
| **Total Non-Current Assets** | $470K | $624K | $764K | $916K | $1.07M | $1.26M | $1.41M | $1.56M |
| **Total Assets** | $7.33M | $6.24M | $6.33M | $8.06M | $7.32M | $5.31M | $7.36M | $6.53M |
| Accounts Payable | $744K | $411K | $385K | $469K | $571K | $571K | $535K | $611K |
| Other Current Liabilities | $294K | $301K | $657K | $219K | $261K | $365K | $472K | -- |
| **Total Current Liabilities** | $1.28M | $1.04M | $1.45M | $1.26M | $1.40M | $1.63M | $1.90M | $1.77M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $87K | $172K | $255K | $337K | $418K |
| **Total Liabilities** | $1.28M | $1.04M | $1.45M | $1.34M | $1.58M | $1.88M | $2.24M | $2.19M |
| **Total Debt (incl. Leases)** | $172K | $255K | $337K | $418K | $497K | $574K | $650K | $725K |
| Common Stock | $1.6K | $477 | $314 | $973 | $761 | $2.6K | $259 | $14K |
| Retained Earnings | -$179.3M | -$176.7M | -$175.1M | -$173.2M | -$171.2M | -$169.7M | -$168.0M | -$161.7M |
| Accumulated Other Comp. Income | -$44K | -$39K | -$33K | -$30K | -$26K | -$22K | -$17K | -$17K |
| **Total Stockholders' Equity** | $6.05M | $5.20M | $4.89M | $6.71M | $5.75M | $3.42M | $5.12M | $4.33M |
| Total Equity | $6.05M | $5.20M | $4.89M | $6.71M | $5.75M | $3.42M | $5.12M | $4.33M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.15M | -$13.39M | -$12.21M | -$12.03M | -$10.42M | -$7.89M | -$6.38M | -$6.22M | -$5.70M | -$7.31M |
| Depreciation & Amortization | $324K | $340K | $359K | $241K | $124K | $40K | $26K | $31K | $36K | $32K |
| Stock-Based Compensation | $279K | $415K | $1.22M | $1.05M | $751K | $779K | $844K | $1.32M | $1.26M | $2.19M |
| Change in Receivables | -- | -- | $0 | $128K | $21K | $58K | -$207K | $75K | -$75K | $199K |
| **Operating Cash Flow** | -$7.00M | -$7.65M | -$10.13M | -$10.51M | -$9.77M | -$6.76M | -$5.20M | -$4.29M | -$3.91M | -$3.51M |
| Capital Expenditure | -$3.7K | $0 | -$251K | -$943K | -$349K | -$60K | -$152K | $0 | -$25K | -$16K |
| **Free Cash Flow** | -$7.00M | -$7.65M | -$10.38M | -$11.45M | -$10.12M | -$6.82M | -$5.35M | -$4.29M | -$3.94M | -$3.52M |
| **Investing Cash Flow** | -$3.7K | $0 | -$251K | -$943K | -$349K | -$60K | -$152K | $0 | -$25K | -$16K |
| Common Stock Issued | $6.90M | $4.70M | $1.32M | $8.93M | $17.46M | $7.26M | $12.16M | $1.34M | $9.63M | $2.76M |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | -$194K | -$279K | -$379K |
| **Financing Cash Flow** | $6.52M | $7.73M | $1.29M | $8.91M | $17.37M | $7.13M | $11.13M | $1.15M | $9.35M | $2.96M |
| **Net Change in Cash** | -$474K | $70K | -$9.09M | -$2.54M | $7.25M | $304K | $5.78M | -- | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.62M | -$1.55M | -$1.88M | -$2.02M | -$1.49M | -$1.76M | -$6.25M | -$1.75M |
| Depreciation & Amortization | $80K | $73K | $80K | $82K | $80K | $83K | $84K | $84K |
| Stock-Based Compensation | $50K | $50K | $61K | $72K | $72K | $72K | $72K | $90K |
| **Operating Cash Flow** | -$1.74M | -$1.90M | -$1.75M | -$1.87M | -$1.66M | -$1.71M | -$1.67M | -$2.01M |
| Capital Expenditure | -$2.2K | -$9.2K | -- | -- | $0 | $0 | $2.2K | -$2.2K |
| **Free Cash Flow** | -$1.74M | -$1.91M | -- | -- | -$1.66M | -$1.71M | -$1.67M | -$2.01M |
| **Investing Cash Flow** | -$2.2K | -$9.2K | -$2.1K | -$1.7K | $0 | $0 | $2.2K | -$2.2K |
| Common Stock Issued | $2.10M | $1.90M | -$848K | $3.25M | $4.50M | $0 | -$681K | $1.84M |
| **Financing Cash Flow** | $3.29M | $1.82M | -$196K | $2.98M | $3.74M | -$5.4K | $2.36M | -$7.1K |
| **Net Change in Cash** | $1.55M | -$93K | -$1.93M | $1.10M | $2.09M | -$1.74M | $686K | -$2.03M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -2072.0% | -3542.5% | -1197.3% | -912.0% | -2612.5% | -3228.8% | -1555.4% |
| **Net Profit Margin** | -- | -- | -- | -2094.9% | -3540.9% | -1196.6% | -980.3% | -2697.8% | -3795.9% | -1855.8% |
| Return on Equity (ROE) | -146.4% | -261.3% | -211.7% | -79.9% | -61.3% | -83.6% | -67.7% | -255.4% | -92.6% | -1075.7% |
| Return on Assets (ROA) | -112.9% | -181.9% | -148.0% | -68.7% | -53.6% | -73.9% | -61.4% | -150.2% | -77.3% | -421.5% |
| Current Ratio | 3.85x | 3.13x | 3.40x | 10.03x | 9.95x | 7.53x | 9.40x | 2.21x | 15.13x | 2.61x |
| Quick Ratio | 3.47x | 2.90x | 2.97x | 0.17x | 9.43x | 7.28x | 9.19x | 2.10x | 14.75x | 2.55x |
| Debt to Equity | 0.07x | 0.13x | 0.16x | 0.08x | 0.04x | 0.00x | 0.01x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -100.0% | +95.2% | -55.4% | +1.4% | +183.2% | +53.5% | -61.8% | -55.8% |
| 5Y Revenue / Share Growth | -- | -- | -- | +283.8% | -- | -- | -- | -- | +9.5% | -- |
| 10Y Revenue / Share Growth | -- | -- | -100.0% | +320.2% | +29.8% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -133.3% | -133.4% | -146.4% | -171.6% | -195.9% | -367.4% | -261.3% | -220.5% |
| Return on Assets (ROA) | -110.0% | -111.3% | -112.9% | -143.0% | -153.7% | -237.1% | -181.9% | -146.5% |
| Current Ratio | 5.37x | 5.42x | 3.85x | 5.68x | 4.45x | 2.49x | 3.13x | 2.80x |
| Quick Ratio | 5.07x | 4.76x | 3.47x | 5.53x | 4.17x | 2.31x | 2.90x | 2.72x |
| Debt to Equity | 0.03x | 0.05x | 0.07x | 0.06x | 0.09x | 0.17x | 0.13x | 0.17x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
